Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →BEL reported a strong Q3 FY26 with 9M revenue of INR 17,302 crore (+19% YoY) and PAT of INR 3,845 crore (+21% YoY).
✓ Verified against BSE filing
BEL reported a strong Q3 FY26 with 9M revenue of INR 17,302 crore (+19% YoY) and PAT of INR 3,845 crore (+21% YoY). EBITDA margin expanded to 30% (up 200bps YoY), driven by favorable product mix and indigenization benefits. Management maintained full-year guidance of 27% EBITDA margin and INR 27,000 crore order inflow, expressing confidence in exceeding both. Key growth drivers include large programs like QRSAM (expected by Q4), NGC (partial in Q4, balance in H1 FY27), and LCA LRUs. The order book stands at INR 73,450 crore, providing strong visibility. Risks include potential spillover of NGC orders and supply chain constraints for semiconductors, though mitigation plans are in place. Overall, the company is well-positioned for sustained 15%+ revenue growth.
BEL ने चालू वित्त वर्ष की तीसरी तिमाही में शानदार प्रदर्शन किया। अब तक 9 महीने में कुल कमाई 17,302 करोड़ रुपये रही, जो पिछले साल से 19% ज्यादा है। मुनाफा 3,845 करोड़ रुपये रहा, जो 21% बढ़ा है। कंपनी की कमाई पर खर्च घटाने की क्षमता (EBITDA मार्जिन) 30% हो गई है, जो पिछले साल से 2% ज्यादा है। इसका कारण अच्छा उत्पाद मिश्रण और देश में ही चीजें बनाने से फायदा है। कंपनी को उम्मीद है कि पूरे साल यह मार्जिन 27% रहेगा और 27,000 करोड़ रुपये के नए ऑर्डर मिलेंगे। बड़े प्रोजेक्ट जैसे QRSAM और NGC से ग्रोथ मिलेगी। अभी कंपनी के पास 73,450 करोड़ रुपये के ऑर्डर हैं, जो आने वाले समय में कमाई की मजबूत संभावना देते हैं। हालांकि, कुछ ऑर्डर में देरी और चिप की कमी का जोखिम है, लेकिन इसके लिए योजना बनाई गई है। कुल मिलाकर, कंपनी 15% से ज्यादा की सालाना कमाई बढ़ोतरी के लिए तैयार है।
0 delivered, 0 close, 2 missed.
View Promises →NGC order spillover risk
View Risks →Full transcript text is available on this route.
Read Transcript →Order book as of Jan 28, 2026; includes INR 19,300 crore of orders acquired YTD.
Management confident of crossing INR 27,000 crore order inflow for FY26.
FY26 R&D spend target; 20%+ YoY growth planned going forward.
Average indigenization across products; ranges from 50% to 90%+.
Management reiterated guidance of >15% revenue growth for FY26, confident of achieving or exceeding.
Management maintained EBITDA margin guidance of 27% for FY26, despite 9M margin of 30%.
Management confident of crossing INR 27,000 crore order inflow for FY26, with potential upside.
R&D spend target for FY26; management expects to cross INR 1,700 crore.
Only 20-25% of NGC orders expected by March; balance may spill to H1 FY27, impacting near-term order inflow.
Shortage of certain semiconductor chips could impact production; management has mitigation plans but risk remains.
Programs like QRSAM and Kusha may have lower margins due to higher outsourcing, potentially pressuring overall margins.
Akash NG order may slip to FY28; other programs like Shatrughat/Samghat face delays, affecting order pipeline.
QRSAM order expected by March 2026, but FOPM phase will take 12-18 months, pushing meaningful revenue recognition to FY28. Any delays in trials or production could impact future revenue.
L&T has partnered with General Atomics for the 87 MALE UAV program (INR 30,000 crore). BEL's role is uncertain; management was evasive on whether they will lead or partner, indicating potential competitive pressure.
Management acknowledged that electronics component availability challenges could cause 5-10% delivery overspill, impacting execution timelines.
Fourth PRC (pay revision for PSU employees) effective from Jan 2027 could increase employee costs by 10-15%, though management expects volume growth to offset.
Mentioned in Q1 FY25, Q3 FY25, Q4 FY25
The INR 30,000 crore QRSAM order may slip to Q1 FY27 due to procedural delays, impacting order inflow guidance.
Mentioned in Q1 FY25, Q1 FY26, Q2 FY25
Q1 revenue was impacted by ~INR 200 crore due to Israel-Iran conflict affecting component supplies; similar disruptions could recur.
Mentioned in Q1 FY26, Q3 FY25
Eighth Pay Commission and PSU pay revision could increase employee costs from FY2028, though management expects growth to offset.
Mentioned in Q1 FY25, Q3 FY25
A provision of ~₹600 crore was made for liquidated damages due to supply delays, indicating execution risks.
Management reiterated guidance of >15% revenue growth for FY26, confident of achieving or exceeding.
Only 20-25% of NGC orders expected by March; balance may spill to H1 FY27, impacting near-term order inflow.
View Risks →